CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 150 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $330,000 | -25.5% | 537,236 | +23.5% | 0.01% | -22.2% |
| Q3 2021 | $443,000 | -33.6% | 434,874 | +19.2% | 0.01% | -25.0% |
| Q2 2021 | $667,000 | +182.6% | 364,964 | +204.2% | 0.01% | +200.0% |
| Q1 2021 | $236,000 | +81.5% | 119,988 | +14.9% | 0.00% | +33.3% |
| Q4 2020 | $130,000 | -23.5% | 104,408 | +10.4% | 0.00% | -50.0% |
| Q3 2020 | $170,000 | -82.8% | 94,608 | -19.8% | 0.01% | -88.2% |
| Q2 2020 | $989,000 | +1.1% | 117,992 | -20.6% | 0.05% | -23.9% |
| Q1 2020 | $978,000 | – | 148,542 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
| AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
| DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
| GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
| Aries Wealth Management | 27,900 | $160,000 | 0.10% |
| Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
| Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
| HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
| WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |